Stock screenerAll disclosures →
EDGAR →
CRBP
Conviction 34HealthcareScan · Mon, Aug 10, 2026CRBP$9.47-6.88%
ResistanceSupportVol 14Insider buyVol MA14 320.87K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.47
Change-6.88%
Gap-0.64%
Rel volume4.33×
Avg volume291.92K
Avg $ vol2.7M
SMA 209.17
SMA 508.72
SMA 2009.54
Price vs 50+8.62%
Price vs 200-0.72%
MA stackmixed
50/200 cross—
Supertrendup · 8.47
RSI (14)54
MACD hist0.07
MACD crossbull · 3d
Stoch %K / %D53 / 80
ADX (14)11
+DI / −DI22 / 17
RSI divergence—
MACD divergence—
ATR %+5.65%
ADR %5.37%
52w high19.36
52w low7.38
From 52w high-51.08%
Above 52w low+28.32%
New 52w highNo
SqueezeOn · 13d
Bollinger width14.71%
%B0.72
Donchian pos55.75%
Donchian high10.24
Donchian low8.50
AVWAP (52w high)9.97
vs AVWAP high-5.03%
AVWAP (52w low)8.70
vs AVWAP low+8.86%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d4.33×
Avg vol (14d)320.87K
Avg vol (20d)291.92K
Avg $ vol (20d)2.7M
Market cap183.16M
RS 3m (vs SPY)-12.14%
RS 6m (vs SPY)+23.50%
RS line new highNo
Trend template1/8
Technical rank63.0
1 week+6.17%
1 month-2.17%
3 months-13.59%
6 months+20.95%
1 year+5.22%
YTD+20.33%
P/E-2.33
P/B1.79
P/S—
P/FCF-2.84
EPS-5.90
Div yield—
ROE-76.82%
ROA-61.85%
Debt/Eq0.12
Current5.71
EV/EBITDA-2.03
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-95.32%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value172.56M
Revenue0
Net income-35.04M
Gross profit—
Free cash flow-64.5M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.53M
Employees36
ListedFri, Oct 24, 2014
Free float15.91M
Float %89.7%
Short interest2.1M
Days to cover5.9d
Short volume36.9%
Squeeze score66 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank63.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.71
Support8.56
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CRBP
No recent disclosed trades by Congress in CRBP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CRBP · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-03 | Buy | 9K | $68K | 2026-06-03 | 2026-06-03 |
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-02 | Buy | 4.5K | $33K | 2026-06-02 | 2026-06-03 |
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-05-21 | Grant | 58.3K | $0 | 2026-05-21 | 2026-05-22 |
Saxena Nishant C Chief Business Officer · Stock options (right to buy) · 2026-05-21 | Grant | 192.3K | $0 | 2026-05-21 | 2026-05-22 |
Kung Winston Director · Stock options (right to buy) · 2026-05-19 | Grant | 12.3K | $0 | 2026-05-19 | 2026-05-21 |
Ben Yong Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Jacques Rachelle Suzanne Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Altmeyer Anne Director · Stock options (right to buy) · 2026-05-19 | Grant | 12.3K | $0 | 2026-05-19 | 2026-05-21 |
Jenkins John Kenneth Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Altmeyer Anne Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in CRBP · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.